THI Cardiology Fellow Segar Presents at ACC National Meeting

Matthew Segar, MD, a first-year Cardiology Fellow, recently represented the Texas Heart Institute at the American College of Cardiology’s national meeting, ACC.22, in Washington, DC. On behalf of an international team of clinical investigators, Dr. Segar presented a moderated poster in the Prevention and Health Promotion category entitled, “Efficacy of ertugliflozin on heart failure hospitalization and HF death across the WATCH-DM risk score: a secondary analysis of the VERTIS CV trial.” Dr. Segar’s participation in the ACC meeting is part of the organization’s Fellows-in-Training (FIT) program, which advocates for resources to help fellows, residents, and medical students succeed in their training and subsequent careers in cardiovascular medicine.

The ACC is a nonprofit medical organization for cardiologists and other cardiovascular care professionals in the United States, Canada, and around the world. Founded in 1949, the ACC bestows credentials on professionals and accreditation to hospitals and institutions. Cardiologists elected to fellowship in the ACC can use the designation “FACC” professionally. In addition to hosting their Annual Scientific Sessions meeting, the ACC advances cardiovascular medicine through the development of clinical guidelines and publication of the JACC family of cardiovascular specialty and subspecialty journals.

Fellows are encouraged to participate in meetings and other educational opportunities through the ACC, with complimentary ACC membership during their three years of training. The Cardiovascular Disease Fellowship program at THI also encourages trainees to take advantage of the meetings and other educational opportunities provided by ACC and other national professional organizations. The fellowship’s Program Director, Stephanie Coulter, MD, FACC, FASE, said, “Activities like Dr. Segar’s presentation at ACC enhance fellows’ training and provide extremely valuable professional network opportunities that will benefit them throughout their careers. As physicians, we need to be lifelong learners to provide the best patient care possible, and the information shared at these meetings—and through those professional networks—is crucial to that process.”

Other THI-affiliated physicians with research presented at the meeting included Drs. Yochai Birnbaum, Wilson Lam, and Nilesh Mathuria.


Read the Abstracts from ACC.22

THI Cardiovascular Disease Fellow

Matthew Segar, MD

Efficacy of ertugliflozin on heart failure hospitalization and HF death across the WATCH-DM risk score: a secondary analysis of the VERTIS CV trial


THI Professional Staff

Yochai Birnbaum, MD

Outcomes and resource utilization in patients hospitalized with gastrointestinal bleeding complicated by types 1 and 2 myocardial infarction

Nilesh Mathuria, MD

Ventricular tachycardia prior to continuous flow left ventricular assist device implantation was not associated with reduced survival: a single center experience

Multiple anti-arrhythmic drugs did not lead to reduction in ICD shocks in a continuous flow LVAD population: a single center experience


THI Teaching Staff

Wilson Lam, MD

Catheter ablation of atrial fibrillation in transposition of the great arteries with atrial switch and pulmonary venous baffle stent

When is STE not a STEMI?

Diagnosing congenital heart disease at 63 years old

Novel approach to diagnostic heart catheterization in a patient with mechanical prosthetic tricuspid valve and tortuous pulmonary arteries

Better late than never: definitive repair of dextro-transposition of the great arteries (D-TGA)/ventricular septal defect/pulmonary stenosis (PS) in a 55 year old male

Snare extraction of right ventricular pacemaker lead via right subclavian vein access